Department of Vascular Surgery, Andreas Papandreou General Hospital
Rhodes, South Aegean, 85133, Greece
NCT Number: NCT04758728
Aim of the present study is to investigate the efficiency of adrenaline (epinephrine) used locally in reducing and avoiding post-operative formation of subcutaneous ecchymoses and hematomas, in comparison with traditional practice of hemostasis, and to assess improvement in the quality of life of subjects undergoing classic great saphenous vein stripping, who received or did not receive adrenaline as a local hemostatic.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Rhodes, South Aegean, 85133, Greece
Introduction Quality of life of subjects undergoing classic great saphenous vein stripping is analogous of the gravity of subcutaneous ecchymoses and hematomas formation, as a result of surgical interventions during open surgery, when the great saphenous vein is being removed. Adrenaline (epinephrine) is a potent vasoconstrictor, whose local hemostatic ability has already been documented and applied in many medical specialties. Aim of the present study to investigate the efficiency of adrenaline (epinephrine) used locally in reducing and avoiding post-operative formation of subcutaneous ecchymoses and hematomas, in comparison with traditional practice of hemostasis, and to assess improvement in the quality of life of subjects undergoing classic great saphenous vein stripping, who received or did not receive adrenaline as a local hemostatic.
Material-Methods 40 subjects diagnosed with chronic venous insufficiency (CVI) and/or varicose veins of the lower limbs of varied clinical gravity (CEAP classification II & III), admitted in the department of Vascular Surgery for open surgical management, i.e. great saphenous vein stripping +/- removal of varicosities, will be enrolled after signing an informed consent for their participation in the study. They will be then randomized into 3 separate groups: Group A - great saphenous vein stripping with local adrenaline use for hemostasis Group B - great saphenous vein stripping with local normal saline use for hemostasis Group C - great saphenous vein stripping with traditional hemostatic practice Study subjects will be followed-up after surgery, and in each group measurement of ecchymoses (small 2-5mm2 and large >5mm2) and hematomas (medium 0,2-1cm and large >1cm) will be performed by using ImageJ software after digital high-resolution photographing on 1st, 8th and 14th post-operative days. Quality of life of subjects will be assessed pre-operatively and 1 month post-operatively, by using SF-36 and CIVIQ-2 questionnaires for QoL in CVI.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Removal of the great saphenous vein (partially - from just below the knee up to the saphenofemoral junction) by two 3cm skin and subcutaneous fat incisions and the introduction of a conventional vein stripper device, under general or epidural/regional anesthesia. Removal of varicose veins of the lower limb by 0,5cm skin incisions and the use of a conventional phlebectomy stainless steel hook. Mechanical hemostasis by direct compression of the thigh for 10 minutes.
Other names: Saphenectomy
Use of epinephrine/adrenaline solution 1:1000 topically
Other names: Adrenaline solution 1:1000 topical/local use
Use of normal saline solution NaCl 0,9% topically
Other names: NaCl 0,9% topical/local use
Time frame: 24 hours post-operatively
The absolute number of subcutaneous ecchymoses on the operated limb on 1st post-operative day
Time frame: 192 hours post-operatively
The absolute number of subcutaneous ecchymoses on the operated limb on 8th post-operative day
Time frame: 336 hours post-operatively
The absolute number of subcutaneous ecchymoses on the operated limb on 14th post-operative day
Time frame: 24 hours post-operatively
The absolute number of subcutaneous hematomas in the operated limb on 1st post-operative day
Time frame: 192 hours post-operatively
The absolute number of subcutaneous hematomas in the operated limb on 8th post-operative day
Time frame: 336 hours post-operatively
The absolute number of subcutaneous hematomas in the operated limb on 14th post-operative day
Time frame: 24 hours post-operatively
The total area in mm2 of subcutaneous ecchymoses in the operated limb on 1st post-operative day
Time frame: 192 hours post-operatively
The total area in mm2 of subcutaneous ecchymoses in the operated limb on 8th post-operative day
Time frame: 336 hours post-operatively
The total area in mm2 of subcutaneous ecchymoses in the operated limb on 14th post-operative day
Time frame: 24 hours post-operatively
The total area in mm2 of subcutaneous hematomas in the operated limb on 1st post-operative day
Time frame: 192 hours post-operatively
The total area in mm2 of subcutaneous hematomas in the operated limb on 8th post-operative day
Time frame: 336 hours post-operatively
The total area in mm2 of subcutaneous hematomas in the operated limb on 14th post-operative day
Time frame: 24 hours pre-operatively
Quality of life assessment based on the 36-Item Short Form Survey (SF-36) questionnaire preoperatively. It is an often-used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study. It taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. The eight scaled scores, which are the weighted sums of the questions in their section are directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Time frame: 30 days post-operatively
Quality of life assessment based on the 36-Item Short Form Survey (SF-36) questionnaire 30 days post-operatively. It is an often-used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study. It taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. It also includes a single item that provides an indication of perceived change in health. The eight scaled scores, which are the weighted sums of the questions in their section are directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Time frame: 24 hours pre-operatively
Quality of life assessment based on the ChronIc Venous Insufficiency quality of life Questionnaire version 2 (CIVIQ-2) questionnaire preoperatively. The CIVIQ was developed and validated (relevance, acceptability, reliability, construct validity, and sensitivity) by French researchers in 1996. The CIVIQ is a 20-item self-reported instrument that includes four categories of questions: physical (4 items), psychological (9 items), social (4 items), and pain (3 items). Its score ranges from 0, the worst score, to 100, the best. There are five possible answers (from 1 to 5) to describe each symptom and the sensation of discomfort. The second version, the CIVIQ-2 (where 2 denotes the second draft of the same questionnaire), provides a global score covering all aspects of the questionnaire and weighs the categories equally.
Time frame: 30 days post-operatively
Quality of life assessment based on the CIVIQ-2 questionnaire 1 month post-operatively. Quality of life assessment based on the ChronIc Venous Insufficiency quality of life Questionnaire version 2 (CIVIQ-2) questionnaire preoperatively. The CIVIQ was developed and validated (relevance, acceptability, reliability, construct validity, and sensitivity) by French researchers in 1996. The CIVIQ is a 20-item self-reported instrument that includes four categories of questions: physical (4 items), psychological (9 items), social (4 items), and pain (3 items). Its score ranges from 0, the worst score, to 100, the best. There are five possible answers (from 1 to 5) to describe each symptom and the sensation of discomfort. The second version, the CIVIQ-2 (where 2 denotes the second draft of the same questionnaire), provides a global score covering all aspects of the questionnaire and weighs the categories equally.
Time frame: 24 hours pre-operatively
Hematocrit (HCT) measured pre-operatively, in percentage (%).
Time frame: 24 hours post-operatively
Hematocrit (HCT) measured post-operatively, in percentage (%).
Time frame: 24 hours pre-operatively
Hemoglobin (Hgb) measured pre-operatively, in mg/dL.
Time frame: 24 hours post-operatively
Hemoglobin (Hgb) measured post-operatively, in mg/dL.
Time frame: 24 hours pre-operatively
White blood cells (WBC) count measured pre-operatively, in K/mcL.
Time frame: 24 hours post-operatively
White blood cells (WBC) count measured post-operatively, in K/mcL.
Time frame: 24 hours pre-operatively
Platelet count (PLT) measured pre-operatively, in K/mcL.
Time frame: 24 hours post-operatively
Platelet count (PLT) measured post-operatively, in K/mcL.
Time frame: 24 hours pre-operatively
Fibrinogen (FIB) measured pre-operatively, in mg/dL.
Time frame: 24 hours post-operatively
Fibrinogen (FIB) measured post-operatively, in mg/dL.
Time frame: 24 hours pre-operatively
Erythrocyte sedimentation rate on the 1st hour, measured pre-operatively, in millimeters (mm).
Time frame: 24 hours post-operatively
Erythrocyte sedimentation rate on the 1st hour, measured post-operatively, in millimeters (mm).
Time frame: 24 hours pre-operatively
Serum C-reactive protein (CRP) measured pre-operatively, in mg/L.
Time frame: 24 hours post-operatively
Serum C-reactive protein (CRP) measured post-operatively, in mg/L.
Time frame: 24 hours pre-operatively
Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.
Time frame: 24 hours post-operatively
Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.
Time frame: 192 hours post-operatively
Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.
Time frame: 336 hours post-operatively
Pain experienced pre-operatively assessed by a numeric rating pain scale (0-10). Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0 indicates no pain, 5 moderate and 10 worst possible pain.
Junior Doctors Network-Hellas
Other
The Role of Adrenaline in the Reduction of Subcutaneous Ecchymoses and Hematomas and in the Improvement of the Quality of Life of Patients After Classic Great Saphenous Vein Stripping
Acronym: ARESQOLSAVES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04180137
Cardiovascular Diseases, Endothelial Dysfunction
Moscow, Russia
View Trial DetailsNCT07699796
Cardiovascular Diseases, Embolism and Thrombosis
Fresno, California, United States
View Trial DetailsNCT06054737
Cardiovascular Diseases, Vascular Diseases
Royat, Auvergne, France
View Trial DetailsNCT07577141
Cardiovascular Diseases, Doppler Ultrasound Diagnosis
View Trial Details